Drägerwerk AG & Co. KGaA (DRW8) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Drägerwerk AG & Co. KGaA (DRW8) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€74.80 Million ≈ $87.45 Million USD) by net assets (€1.51 Billion ≈ $1.76 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Drägerwerk AG & Co. KGaA (DRW8) liquidity interval to measure how many days the company can operate on defensive assets alone.

Drägerwerk AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Drägerwerk AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Drägerwerk AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Drägerwerk AG & Co. KGaA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Festi hf
IC:FESTI
-0.001x
Huayi Compressor Co Ltd
SHE:000404
0.032x
Zhejiang Damon Technology Co Ltd
SHG:688360
0.105x
ADITYA VISION LTD
NSE:AVL
0.212x
UWM Holdings Corp
NYSE:UWMC
-1.393x
Supriya Lifescience Limited
NSE:SUPRIYA
0.051x
Kri-Kri Milk Industry S.A
AT:KRI
0.059x
Molinos Agro SA
BA:MOLA
-1.906x

Annual Cash Flow Conversion Efficiency for Drägerwerk AG & Co. KGaA (2005–2024)

The table below shows the annual cash flow conversion efficiency of Drägerwerk AG & Co. KGaA from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see DRW8 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €1.54 Billion
≈ $1.80 Billion
€167.31 Million
≈ $195.60 Million
0.109x -19.11%
2023-12-31 €1.41 Billion
≈ $1.65 Billion
€189.68 Million
≈ $221.75 Million
0.135x +223.13%
2022-12-31 €1.32 Billion
≈ $1.54 Billion
€-144.23 Million
≈ $-168.62 Million
-0.109x -135.80%
2021-12-31 €1.26 Billion
≈ $1.47 Billion
€384.89 Million
≈ $449.97 Million
0.305x -31.37%
2020-12-31 €1.03 Billion
≈ $1.21 Billion
€459.98 Million
≈ $537.76 Million
0.445x +191.27%
2019-12-31 €1.08 Billion
≈ $1.26 Billion
€164.42 Million
≈ $192.22 Million
0.153x +3936.11%
2018-12-31 €1.08 Billion
≈ $1.26 Billion
€4.09 Million
≈ $4.78 Million
0.004x -97.18%
2017-12-31 €1.07 Billion
≈ $1.25 Billion
€143.34 Million
≈ $167.57 Million
0.134x -31.07%
2016-12-31 €1.00 Billion
≈ $1.17 Billion
€195.32 Million
≈ $228.35 Million
0.195x +361.89%
2015-12-31 €945.93 Million
≈ $1.11 Billion
€39.86 Million
≈ $46.60 Million
0.042x -79.90%
2014-12-31 €896.61 Million
≈ $1.05 Billion
€187.98 Million
≈ $219.77 Million
0.210x +150.33%
2013-12-31 €815.97 Million
≈ $953.95 Million
€68.34 Million
≈ $79.90 Million
0.084x -65.54%
2012-12-31 €727.20 Million
≈ $850.17 Million
€176.75 Million
≈ $206.64 Million
0.243x +10.90%
2011-12-31 €729.62 Million
≈ $853.00 Million
€159.91 Million
≈ $186.95 Million
0.219x -36.34%
2010-12-31 €636.56 Million
≈ $744.21 Million
€219.14 Million
≈ $256.20 Million
0.344x -29.92%
2009-12-31 €393.82 Million
≈ $460.42 Million
€193.45 Million
≈ $226.17 Million
0.491x +160.88%
2008-12-31 €517.64 Million
≈ $605.18 Million
€97.47 Million
≈ $113.95 Million
0.188x -39.66%
2007-12-31 €505.49 Million
≈ $590.97 Million
€157.75 Million
≈ $184.42 Million
0.312x +88.90%
2006-12-31 €539.99 Million
≈ $631.31 Million
€89.21 Million
≈ $104.29 Million
0.165x +41.12%
2005-12-31 €257.68 Million
≈ $301.25 Million
€30.16 Million
≈ $35.27 Million
0.117x --

About Drägerwerk AG & Co. KGaA

XETRA:DRW8 Germany Medical Devices
Market Cap
$824.34 Million
€705.10 Million EUR
Market Cap Rank
#9954 Global
#1201 in Germany
Share Price
€69.40
Change (1 day)
-2.25%
52-Week Range
€51.00 - €77.40
All Time High
€77.40
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more